The Mumbai-based company, Sudarshan Pharma Industries Limited was originally incorporated as ‘Sudarshan Specialty Chemsolve Private Limited. Incorporated in 2008, the organisation supplies chemicals, export and import activities, intermediates, and APIs (Active Pharmaceutical Ingredients).
They outsource the production facility to suppliers in India and other countries as per the client’s requirements. The company’s product is mostly used across various industries, including the pharma, food, paint, and adhesive industries.
The organisation provides medicine and pharmaceutical formulations to hospitals, NGOs, and the government by involving itself in a contract manufacturing facility. They have a total of 50 pharmaceutical formulations that are sold under the brand name in the form of ointments, tablets, injectables, and capsules.
Further, they offer customised solutions, along with QC (quality control) services and formulation development.
Here are the competitive strengths of the company:
A strong network for distribution, marketing, and sales.
Focusing on quality delivery and customer requirements
They offer various products range
Diversified commercial ventures
Purpose of issuing an IPO
To fulfill working capital requirements
To expand production facilities for the pharmaceutical business